Modulation of platelet-activating factor synthesis by recombinant interferon-α in human renal cell carcinoma

Urologia Internationalis

Volumn 57, Issue 1, 1996, Pages 11-16

  Imagawa, Masaharu ^a   Mimata, Hiromitsu ^a   Takahashi, Shin Ichi ^a   Nakagawa, Masayuki ^a   Nomura, Yoshio ^a   Ogata, Jiro ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Choline phosphotransferase; Interferon; Platelet activating factor; Renal cell carcinoma

Indexed keywords

CHOLINEPHOSPHOTRANSFERASE; RECOMBINANT ALPHA INTERFERON; THROMBOCYTE ACTIVATING FACTOR;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY CARCINOMA; KIDNEY CORTEX; KIDNEY MEDULLA; MALE; NEPHRECTOMY; PRIORITY JOURNAL;

EID: 0030036306     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000282869     Document Type: Article

References (20)

1. Hanahan DJ: Platelet-activating factor: A biologically active phosphoglyceride. Annu Rev Biochem 1986;55:483-509
2. Benveniste J, Vargatig BB: Platelet-activating factor: An ether lipid with biological activity: in Mangold HK, Paltoouf F (eds): Ether Lipids: Biochemical and Biomedical Aspects. New York. Academic Press. 1983. pp 355-376.
3. Braquet P, Touqui LM, Shen TY, Vargaftig BB: Perspectives in platelet-activating factor research. Pharmacol Rev 1987;39:97-145.
4. Marathc GK, Krishnakantha TP, D’Souza CJM: PAF-accther in AK.-5 tumor cells. Cell Biol Int Rep 1991;15:85-90.
5. Pitton C, Lanson M, Besson P, Fetissoff F, Lansac J, Benveniste J, Bougnoux P: Presence of PAF-accthcr in human breast carcinoma: Relation to axillary lymph node metastasis. J Natl Cancer Inst 1989:81:1298-1302.
6. Schlondorff D, Neuwirth R: Platelet-activating factor and kidney. Am J Physiol 1986:251: 1-11.
7. Camussi G, Salvidio G, Tetta C: Platelet-activating factor in renal diseases. Am J Nephrol 1989;9(suppl 1):23-26.
8. Zacharski LR, Memoli VA, Rousseau SM: Co-agulation-canccr interaction in situ in renal cell carcinoma. Blood 1986;68:394-399.
9. Markovic SN, Murasko DM: Neoadjuvant immunotherapy with interferon of the spontaneously metastasizing murine BI6F10L. melanoma. Int J Cancer 1990:45:788-794.
10. Markovic SN, Murasko DM: Role of natural killer and T-cells in interferon-induced inhibition of spontaneous métastases of the B16F10L murine melanoma. Cancer Res 1991:51:1124-1128.
11. Hermanck P, Sobin LH: TNM Classification of Malignant Tumours, ed 4. Berlin. Springer. 1987.
12. Hcrmanek P, Siegel A, Chlepas S: Histological grading of renal cell carcinoma. Eur Urol 1976; 2:189-191.
13. Bligh EG, Dye WJ: A rapid method of total lipid extraction and purification. Can J Biochcm Physiol 1959;37:911-917.
14. Renooij W, Snyder F: Biosynthesis of 1-alkyl-2-acetyl-, v-glycero-3-phosphochoIine (platelet-activating factor and a hypotensive lipid) by cholinephosphotransfcrasc in various rat tissues. Biochim Biophys Acta 1981:663:545-556.
15. Lowry OH, Rosebrough AL. Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
16. Woodard DS, Lee T-C, Snyder F: The final step in the dc novo biosynthesis of platelet-activating factor. Properties of a unique CDP-choline: 1 -alkyl-2-acetyl-SH-glycerol cholinc-phospho-transferase in microsomes from the renal inner medulla of rats. J Biol Chem 1987;262:2520-2527.
17. Aarsman AJ, Neys FW, Van den Bosch H: Catabolism of platelet-activating factor and its acyl analog. Differentiation of the activities of lysophospholipasc and platclet-activating-fac-tor acetylhydrolase. Eur J Biochem 1991:200: 187-193.
18. Moochhala SM, Renton KW, Stebbing N: Induction and depression of cytochrome P450-dependent mixcd-function oxidase by a cloned consensus a-intcrferon IFN-a CONO in the hamster. Biochem Pharmacol 1989:38:439-447.
19. Ghezzi P, Bianchi M, Mantovani A, Spreaftco F, Salmona M: Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. Biochem Biophys Res Com-mun 1984;119:149.
20. Ghezzi P, Bianchi M, Gianera L, Landolfo S, Salmona M: Role of reactive oxygen intermediates in the interferon-mediated depression of hepatic drug metabolism and protective effect of N-acetylcysteine in mice. Cancer Res 1985; 45:3444-3447.